{"id":1977,"date":"2025-05-31T03:07:39","date_gmt":"2025-05-31T03:07:39","guid":{"rendered":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/"},"modified":"2025-05-31T03:07:48","modified_gmt":"2025-05-31T03:07:48","slug":"artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care","status":"publish","type":"post","link":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/","title":{"rendered":"Artera to Present Validation Data at 2025 ASCO Annual Meeting Showcasing How Its Multimodal AI Platform is Advancing Personalized Cancer Care"},"content":{"rendered":"

<\/p>\n
<\/figure>\n

<\/center><\/p>\n

Artera Showcases Breakthrough Prostate Cancer Validation Data at ASCO 2025<\/h2>\n

Artera<\/b>, a trailblazer in oncology diagnostics leveraging multimodal artificial intelligence (MMAI), has unveiled exciting advancements in prostate cancer care at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The company\u2019s cutting-edge MMAI platform forms the foundation for two new research abstracts presented at the prestigious event\u2014one of which earned the coveted Best of ASCO 2025<\/b> distinction.<\/p>\n

Revolutionizing Cancer Care with Multimodal Artificial Intelligence<\/h3>\n

Artera has developed a platform that fuses diverse data types\u2014clinical, radiological, and pathological\u2014to create more personalized and effective treatment plans for cancer patients. Its novel approach is designed to enhance prognostic accuracy and treatment prediction, particularly in prostate cancer where individualized therapy decisions can significantly impact outcomes.<\/p>\n

The company\u2019s MMAI-powered test is unique in that it integrates multiple data sources, including digitized histopathology slides and clinical variables, to predict both the potential trajectory of prostate cancer and the patient\u2019s likely response to various treatment courses.<\/p>\n

Award-Winning Research Highlighted at ASCO 2025<\/h4>\n

Artera’s presence at ASCO 2025 marks a major milestone in validating its MMAI technology in clinical settings. Of the two studies presented, one was selected for an oral presentation<\/b>\u2014a format reserved for the most impactful scientific research. Even more notably, it was chosen for the Best of ASCO 2025<\/b>, underscoring its significant contributions to transforming oncology care.<\/p>\n

What This Means for Prostate Cancer Treatment<\/h5>\n

The newly released data provides robust clinical validation of Artera\u2019s MMAI test in identifying which patients with localized prostate cancer will benefit most from intensified treatments such as radiation therapy with androgen deprivation therapy (ADT)<\/b>. By offering this prognostic insight at diagnosis, the platform allows oncologists to better tailor treatment to the individual\u2014avoiding over-treatment in low-risk patients and improving outcomes for those with high-risk profiles.<\/p>\n

Key advantages of Artera’s MMAI test include:<\/p>\n

    \n
  • Early Identification<\/b> of high-risk patients who may benefit from more aggressive, multi-modal treatments.<\/li>\n
  • Reduction in Overtreatment<\/b>, sparing low-risk patients from unnecessary side effects while maintaining efficacy.<\/li>\n
  • Integration into Existing Clinical Workflows<\/b>, ensuring that physicians can seamlessly incorporate the test into routine decision-making.<\/li>\n<\/ul>\n

    Looking Ahead: Wider Adoption and Continued Validation<\/h4>\n

    Artera\u2019s momentum at ASCO is expected to boost clinical adoption of its MMAI platform across leading cancer centers worldwide. As healthcare continues to evolve toward personalized and data-driven care, Artera\u2019s AI-powered tools are well-positioned to address long-standing gaps in cancer diagnosis and treatment.<\/p>\n

    The company plans to continue expanding its platform across other types of cancers, further refining its predictive capabilities and clinical utility. <\/p>\n

    Quotes from Industry Leaders<\/h5>\n

    While specific quotes were not provided in the original announcement, it\u2019s clear that Artera\u2019s work is resonating with oncology professionals. Being recognized by ASCO with a Best of ASCO 2025 presentation reflects that peer-reviewed experts believe the technology will play a pivotal role in shaping the future of precision oncology.<\/p>\n

    Conclusion: A Promising Horizon for AI in Cancer Diagnostics<\/h3>\n

    With its presentations at ASCO 2025, Artera has firmly established itself as a leader in the application of multimodal AI for cancer prediction and treatment optimization. By delivering validated, clinically actionable insights directly from diagnosis, Artera stands to redefine the prostate cancer care paradigm.<\/p>\n

    For clinicians and healthcare systems seeking more precise tools in the fight against cancer, Artera offers a glimpse into a smarter, more personalized future\u2014one where artificial intelligence doesn\u2019t just assist doctors but genuinely transforms the trajectory of patient outcomes.<\/p>\n

    Stay connected for more updates from ASCO 2025 and the emerging role of AI in oncology.<\/h6>\n","protected":false},"excerpt":{"rendered":"

    Artera Showcases Breakthrough Prostate Cancer Validation Data at ASCO 2025 Artera, a trailblazer in oncology diagnostics leveraging multimodal artificial intelligence (MMAI), has unveiled exciting advancements in prostate cancer care at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The company\u2019s cutting-edge MMAI platform forms the foundation for two new research abstracts presented at […]<\/p>\n","protected":false},"author":1,"featured_media":1975,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2,12],"tags":[],"class_list":["post-1977","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligent","category-all-posts"],"acf":[],"yoast_head":"\nArtera to Present Validation Data at 2025 ASCO Annual Meeting Showcasing How Its Multimodal AI Platform is Advancing Personalized Cancer Care - Yeap Technology News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Artera to Present Validation Data at 2025 ASCO Annual Meeting Showcasing How Its Multimodal AI Platform is Advancing Personalized Cancer Care - Yeap Technology News\" \/>\n<meta property=\"og:description\" content=\"Artera Showcases Breakthrough Prostate Cancer Validation Data at ASCO 2025 Artera, a trailblazer in oncology diagnostics leveraging multimodal artificial intelligence (MMAI), has unveiled exciting advancements in prostate cancer care at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The company\u2019s cutting-edge MMAI platform forms the foundation for two new research abstracts presented at […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Yeap Technology News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/YeapTechnology\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-31T03:07:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-31T03:07:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/05\/1UjfHPEQm6zh6VU2B2gLbjHO12XsKKyxy90nRkz6M3D.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"dsonson23\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"dsonson23\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/\"},\"author\":{\"name\":\"dsonson23\",\"@id\":\"https:\/\/apps.yeap.technology\/news\/#\/schema\/person\/c14af09cbb85300c66a5d51206c0d7f8\"},\"headline\":\"Artera to Present Validation Data at 2025 ASCO Annual Meeting Showcasing How Its Multimodal AI Platform is Advancing Personalized Cancer Care\",\"datePublished\":\"2025-05-31T03:07:39+00:00\",\"dateModified\":\"2025-05-31T03:07:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/\"},\"wordCount\":605,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/apps.yeap.technology\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/05\/1UjfHPEQm6zh6VU2B2gLbjHO12XsKKyxy90nRkz6M3D.png\",\"articleSection\":[\"AI - Artificial Intelligent\",\"All\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/\",\"url\":\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/\",\"name\":\"Artera to Present Validation Data at 2025 ASCO Annual Meeting Showcasing How Its Multimodal AI Platform is Advancing Personalized Cancer Care - Yeap Technology News\",\"isPartOf\":{\"@id\":\"https:\/\/apps.yeap.technology\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/05\/1UjfHPEQm6zh6VU2B2gLbjHO12XsKKyxy90nRkz6M3D.png\",\"datePublished\":\"2025-05-31T03:07:39+00:00\",\"dateModified\":\"2025-05-31T03:07:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#primaryimage\",\"url\":\"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/05\/1UjfHPEQm6zh6VU2B2gLbjHO12XsKKyxy90nRkz6M3D.png\",\"contentUrl\":\"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/05\/1UjfHPEQm6zh6VU2B2gLbjHO12XsKKyxy90nRkz6M3D.png\",\"width\":1024,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/apps.yeap.technology\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Artera to Present Validation Data at 2025 ASCO Annual Meeting Showcasing How Its Multimodal AI Platform is Advancing Personalized Cancer Care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/apps.yeap.technology\/news\/#website\",\"url\":\"https:\/\/apps.yeap.technology\/news\/\",\"name\":\"Yeap Technology News\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/apps.yeap.technology\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/apps.yeap.technology\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/apps.yeap.technology\/news\/#organization\",\"name\":\"Yeap Technology News\",\"url\":\"https:\/\/apps.yeap.technology\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/apps.yeap.technology\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/01\/yeap-logo-scaled.jpg\",\"contentUrl\":\"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/01\/yeap-logo-scaled.jpg\",\"width\":2560,\"height\":779,\"caption\":\"Yeap Technology News\"},\"image\":{\"@id\":\"https:\/\/apps.yeap.technology\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/YeapTechnology\",\"https:\/\/www.instagram.com\/yeap.technology\",\"https:\/\/www.tiktok.com\/@yeaptechnology\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/apps.yeap.technology\/news\/#\/schema\/person\/c14af09cbb85300c66a5d51206c0d7f8\",\"name\":\"dsonson23\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/apps.yeap.technology\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5e7a9bff5aa300d59e08bfe18bcd9311595fd84c1afa499150d4ce253149d314?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5e7a9bff5aa300d59e08bfe18bcd9311595fd84c1afa499150d4ce253149d314?s=96&d=mm&r=g\",\"caption\":\"dsonson23\"},\"sameAs\":[\"https:\/\/apps.yeap.technology\/news\"],\"url\":\"https:\/\/apps.yeap.technology\/news\/author\/dsonson23\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Artera to Present Validation Data at 2025 ASCO Annual Meeting Showcasing How Its Multimodal AI Platform is Advancing Personalized Cancer Care - Yeap Technology News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/","og_locale":"en_US","og_type":"article","og_title":"Artera to Present Validation Data at 2025 ASCO Annual Meeting Showcasing How Its Multimodal AI Platform is Advancing Personalized Cancer Care - Yeap Technology News","og_description":"Artera Showcases Breakthrough Prostate Cancer Validation Data at ASCO 2025 Artera, a trailblazer in oncology diagnostics leveraging multimodal artificial intelligence (MMAI), has unveiled exciting advancements in prostate cancer care at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The company\u2019s cutting-edge MMAI platform forms the foundation for two new research abstracts presented at […]","og_url":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/","og_site_name":"Yeap Technology News","article_publisher":"https:\/\/www.facebook.com\/YeapTechnology","article_published_time":"2025-05-31T03:07:39+00:00","article_modified_time":"2025-05-31T03:07:48+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/05\/1UjfHPEQm6zh6VU2B2gLbjHO12XsKKyxy90nRkz6M3D.png","type":"image\/png"}],"author":"dsonson23","twitter_card":"summary_large_image","twitter_misc":{"Written by":"dsonson23","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#article","isPartOf":{"@id":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/"},"author":{"name":"dsonson23","@id":"https:\/\/apps.yeap.technology\/news\/#\/schema\/person\/c14af09cbb85300c66a5d51206c0d7f8"},"headline":"Artera to Present Validation Data at 2025 ASCO Annual Meeting Showcasing How Its Multimodal AI Platform is Advancing Personalized Cancer Care","datePublished":"2025-05-31T03:07:39+00:00","dateModified":"2025-05-31T03:07:48+00:00","mainEntityOfPage":{"@id":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/"},"wordCount":605,"commentCount":0,"publisher":{"@id":"https:\/\/apps.yeap.technology\/news\/#organization"},"image":{"@id":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#primaryimage"},"thumbnailUrl":"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/05\/1UjfHPEQm6zh6VU2B2gLbjHO12XsKKyxy90nRkz6M3D.png","articleSection":["AI - Artificial Intelligent","All"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/","url":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/","name":"Artera to Present Validation Data at 2025 ASCO Annual Meeting Showcasing How Its Multimodal AI Platform is Advancing Personalized Cancer Care - Yeap Technology News","isPartOf":{"@id":"https:\/\/apps.yeap.technology\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#primaryimage"},"image":{"@id":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#primaryimage"},"thumbnailUrl":"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/05\/1UjfHPEQm6zh6VU2B2gLbjHO12XsKKyxy90nRkz6M3D.png","datePublished":"2025-05-31T03:07:39+00:00","dateModified":"2025-05-31T03:07:48+00:00","breadcrumb":{"@id":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#primaryimage","url":"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/05\/1UjfHPEQm6zh6VU2B2gLbjHO12XsKKyxy90nRkz6M3D.png","contentUrl":"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/05\/1UjfHPEQm6zh6VU2B2gLbjHO12XsKKyxy90nRkz6M3D.png","width":1024,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/apps.yeap.technology\/news\/artera-to-present-validation-data-at-2025-asco-annual-meeting-showcasing-how-its-multimodal-ai-platform-is-advancing-personalized-cancer-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/apps.yeap.technology\/news\/"},{"@type":"ListItem","position":2,"name":"Artera to Present Validation Data at 2025 ASCO Annual Meeting Showcasing How Its Multimodal AI Platform is Advancing Personalized Cancer Care"}]},{"@type":"WebSite","@id":"https:\/\/apps.yeap.technology\/news\/#website","url":"https:\/\/apps.yeap.technology\/news\/","name":"Yeap Technology News","description":"","publisher":{"@id":"https:\/\/apps.yeap.technology\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/apps.yeap.technology\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/apps.yeap.technology\/news\/#organization","name":"Yeap Technology News","url":"https:\/\/apps.yeap.technology\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/apps.yeap.technology\/news\/#\/schema\/logo\/image\/","url":"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/01\/yeap-logo-scaled.jpg","contentUrl":"https:\/\/apps.yeap.technology\/news\/wp-content\/uploads\/2025\/01\/yeap-logo-scaled.jpg","width":2560,"height":779,"caption":"Yeap Technology News"},"image":{"@id":"https:\/\/apps.yeap.technology\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/YeapTechnology","https:\/\/www.instagram.com\/yeap.technology","https:\/\/www.tiktok.com\/@yeaptechnology"]},{"@type":"Person","@id":"https:\/\/apps.yeap.technology\/news\/#\/schema\/person\/c14af09cbb85300c66a5d51206c0d7f8","name":"dsonson23","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/apps.yeap.technology\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5e7a9bff5aa300d59e08bfe18bcd9311595fd84c1afa499150d4ce253149d314?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5e7a9bff5aa300d59e08bfe18bcd9311595fd84c1afa499150d4ce253149d314?s=96&d=mm&r=g","caption":"dsonson23"},"sameAs":["https:\/\/apps.yeap.technology\/news"],"url":"https:\/\/apps.yeap.technology\/news\/author\/dsonson23\/"}]}},"_links":{"self":[{"href":"https:\/\/apps.yeap.technology\/news\/wp-json\/wp\/v2\/posts\/1977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/apps.yeap.technology\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/apps.yeap.technology\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/apps.yeap.technology\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/apps.yeap.technology\/news\/wp-json\/wp\/v2\/comments?post=1977"}],"version-history":[{"count":1,"href":"https:\/\/apps.yeap.technology\/news\/wp-json\/wp\/v2\/posts\/1977\/revisions"}],"predecessor-version":[{"id":1978,"href":"https:\/\/apps.yeap.technology\/news\/wp-json\/wp\/v2\/posts\/1977\/revisions\/1978"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/apps.yeap.technology\/news\/wp-json\/wp\/v2\/media\/1975"}],"wp:attachment":[{"href":"https:\/\/apps.yeap.technology\/news\/wp-json\/wp\/v2\/media?parent=1977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/apps.yeap.technology\/news\/wp-json\/wp\/v2\/categories?post=1977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/apps.yeap.technology\/news\/wp-json\/wp\/v2\/tags?post=1977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}